Faculdade de Ciências da Nutrição e Alimentação, Universidade do Porto, Porto, Portugal.
J Antimicrob Chemother. 2010 Oct;65(10):2097-100. doi: 10.1093/jac/dkq293. Epub 2010 Aug 4.
To analyse the genetic environment of the bla(CMY-2) gene in a multidrug-resistant isolate belonging to the OXA-30-producing Salmonella enterica serotype Typhimurium clone widespread in European countries.
Preliminary characterization of CMY-2 was performed after determining the phenotype against β-lactams, the pI (isoelectric focusing) and the presence of bla genes (PCR). The genetic context of the bla(CMY-2) gene was identified by PCR mapping and further sequencing. Plasmid analysis included determination of transferability, size and content (S1-PFGE/hybridization), and characterization of the incompatibility group (PCR-based replicon typing, hybridization and sequencing).
The ΔISEcp1-bla(CMY-2)-blc-sugE cassette identified is located in the pndC-trbA region of an IncIγ conjugative plasmid designated pSTHV23035. This plasmid differs from previously described European IncI plasmids coding for CMY in the IncI replicon type and in the integration site of the element carrying bla(CMY-2).
The emergence of bla(CMY-2) located in a new IncIγ plasmid in an isolate belonging to the international widespread multidrug-resistant sequence type (ST) 19 OXA-30-producing Salmonella Typhimurium clone is reported for the first time. Acquisition of a new bla(CMY-2)-IncIγ plasmid by Salmonella multidrug-resistant strains is of concern since these plasmids diminish the activity of therapeutically important broad-spectrum β-lactams and contribute to the persistence and pathogenicity of widespread clones.
分析广泛存在于欧洲国家的产 OXA-30 鼠伤寒沙门氏菌 OXA-30 型克隆中的多重耐药分离株 bla(CMY-2)基因的遗传环境。
在确定对β-内酰胺的表型、pI(等电聚焦)和 bla 基因(PCR)存在后,对 CMY-2 进行初步特征分析。通过 PCR 图谱和进一步测序确定 bla(CMY-2)基因的遗传环境。质粒分析包括可转移性、大小和含量的确定(S1-PFGE/杂交),以及不相容群的特征(基于 PCR 的复制子分型、杂交和测序)。
鉴定出的 ΔISEcp1-bla(CMY-2)-blc-sugE 盒位于被指定为 pSTHV23035 的 IncIγ 可接合质粒的 pndC-trbA 区。该质粒与先前描述的编码 CMY 的欧洲 IncI 质粒在 IncI 复制子类型和携带 bla(CMY-2)的元件的整合位点上有所不同。
首次报道了在属于广泛流行的多药耐药序列型(ST)19 产 OXA-30 鼠伤寒沙门氏菌克隆的分离株中,bla(CMY-2)位于新的 IncIγ 质粒中的情况。由于这些质粒降低了治疗上重要的广谱β-内酰胺的活性,并有助于广泛流行克隆的持续存在和致病性,因此多药耐药的沙门氏菌菌株获得新的 bla(CMY-2)-IncIγ 质粒令人担忧。